Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NanoTears is an over-the-counter **ophthalmic lubricant eye drop** developed by iSolutions for **dry eye disease**. The product uses patented **nano-lipid technology** based on nano-sized lipids called **NanoPids** that are intended to mimic the lipids produced by the Meibomian gland and restore the lipid layer of the tear film, thereby reducing tear evaporation and improving ocular surface lubrication. It is described as a clear ophthalmic solution that converts to a gel on contact with the eye for prolonged symptom relief without the blur associated with traditional opaque emollient eye drops, and is positioned for both aqueous-deficient and evaporative dry eye across multiple severity-specific formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NanoTears.